The EBITDA margin stood at 33% in the reporting quarter compared to 32.7% a year ago. Shares of Caplin Point Laboratories Ltd ended at ₹2,212.25, up by ₹41.65, or 1.92%, on the BSE.
The EBITDA margin stood at 33% in the reporting quarter compared to 32.7% a year ago. Shares of Caplin Point Laboratories Ltd ended at ₹2,212.25, up by ₹41.65, or 1.92%, on the BSE.